Some visit links earn us a commission.
Quick verdict
Hone Health is the better pick for most patients on overall scoring. Hone Health targets men's hormone optimization (testosterone, semaglutide, peptides) with an at-home blood-draw model. GLP-1 added in 2024 as part of the metabolic-optimization product line. Strong for the testosterone+GLP-1 stack; less obesity-medicine depth than Form Health.
That said, Hims & Hers wins on specific dimensions. Same-day prescription, no lock-in and brand-name confidence. Hims pivoted to branded-only in March 2026 after settling with Novo Nordisk; compounded semaglutide is closed to new patients. Headline price is $299/mo branded Wegovy injectable (self-pay), plus $149/mo membership.
Side-by-side
| Hims & Hers | Hone Health | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $185/mo (+ med separate) |
| Monthly cost gap | Hone Health is $114/mo cheaper than Hims & Hers | |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 1 day | 7 days |
| Consultation type | Asynchronous | Video |
| Affiliate network | Impact | Direct |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Hims & Hers | Hone Health | |
|---|---|---|
| Pricing transparency | 6/10 | 6/10 |
| Cancellation terms | 9/10 | 7/10 |
| Onboarding experience | 9/10 | 7/10 |
| Medication options | 5/10 | 7/10 |
| Member reviews | 6/10 | 9.6/10 |
When to choose Hims & Hers
Best for fast async onboarding
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable monthly pricing.
Hims & Hers wins on cancellation terms, onboarding experience on the dimensional scoring. The caveat: Patients who wanted Hims's old compounded semaglutide tier or who need insurance-routed branded access. Compounded is closed to new patients. Note also: Settled with Novo Nordisk March 9, 2026 over compounded semaglutide marketing
When to choose Hone Health
Best for men's hormone plus GLP-1 stack
Men interested in combined hormone-optimization and weight loss. Patients who want at-home blood draws and broader metabolic protocols beyond standard obesity care.
Hone Health wins on medication options, member reviews and runs $114/mo cheaper than Hims & Hers at the entry tier ($185 vs $299). Over a year that's $1,368 you keep. The caveat: Patients seeking obesity-medicine specialization, women's-specific needs or the cheapest cash-pay path. Note also: Hone markets compounded peptides beyond GLP-1; the broader peptide-marketing landscape has higher 2025-2026 regulatory exposure than GLP-1 alone
If cost is your main filter
Hone Health is the cheaper monthly: $185 all-in vs $299 for Hims & Hers. That's $114 a month or $1,368a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $342 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Hims & Hers (month-to-month) and Hone Health (month-to-month) sit at the same cancellation tier. Read both cancellation policies directly before signing; the on-page summary covers the headline but not the deletion-of-account or refund-window edge cases.
FAQ
Is Hims & Hers cheaper than Hone Health?
Can I switch from Hims & Hers to Hone Health mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
